Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Biol Sci. 2014 Apr 8;10(4):457-65. doi: 10.7150/ijbs.7562. eCollection 2014.

Genistein attenuates brain damage induced by transient cerebral ischemia through up-regulation of ERK activity in ovariectomized mice.

Author information

1
1. Department of Anesthesiology, Xijing Hospital, Forth Military Medical University, Xi'an, China; ; 4. Dr Shiquan Wang and Dr Haidong Wei equally contributed to this work.
2
2. Department of Anesthesiology, the Second Affiliated Hospital of Xi'an Jiaotong University College of Medicine, Xi'an, China; ; 4. Dr Shiquan Wang and Dr Haidong Wei equally contributed to this work.
3
3. Department of Psychosomatic Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, China;
4
1. Department of Anesthesiology, Xijing Hospital, Forth Military Medical University, Xi'an, China;

Abstract

Stroke has severe consequences in postmenopausal women. As replacement therapy of estrogen have various adverse effects and the undermined outcomes. Genistein, a natural phytoestrogen, has been suggested to be a potential neuroprotective agent for such stroke patients. However, the role of genistein and its underlying mechanism in ovariectomized mice has not yet been evaluated. In the present study, ovariectomized mice were treated with genistein (10 mg/kg) or vehicle daily for two weeks before developing transient cerebral ischemia (middle cerebral artery occlusion). The neurological manifestation was evaluated, and infarct volumes were demonstrated by 2,3,5-triphenyltetrazolium chloride staining at 24 h after reperfusion. In addition, phosphorylation of extracellular signal-regulated kinase (ERK) was detected by Western blotting and immunofluorescence staining, and cellular apoptosis was evaluated in the ischemic penumbra. We found that treatment with genistein reduced infarct volumes, improved neurological outcomes and attenuated cellular apoptosis at 24 h after reperfusion. ERK1/2 showed increased phosphorylation by genistein treatment after reperfusion, and an ERK1/2 inhibitor U0126 abolished this protective effect of genistein in terms of infarct volumes, neurological scores and cellular apoptosis. Our findings indicate that treatment with genistein can reduce the severity of subsequent stroke episodes, and that this beneficial function is associated with ERK activation.

KEYWORDS:

cerebral ischemia; extracellular signal-regulated protein kinase; genistein; phytoestrogen; postmenopausal stroke.

PMID:
24719563
PMCID:
PMC3979998
DOI:
10.7150/ijbs.7562
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Ivyspring International Publisher Icon for PubMed Central
    Loading ...
    Support Center